Abstract
Achilles tendinopathy (AT) is one of the most common tendon pathologies caused by excessive and repetitive loading [1], affecting both high and medium-level athletes as well as the general population [2,3]. It is a degenerative disorder resulting from a failed tendon healing response [4]. The exact pathophysiology remains unknown and is considered a disorder of a multifactorial aetiology [5] involving both endogenous and exogenous factors [2,6,7]. Clinical symptoms include pain, swelling and decreased function [3,7,8,9]. AT has a considerable negative impact on quality of life, work productivity, and participation in sports. These factors, along with increasing healthcare expenses, highlight the requirement for optimizing the therapeutic strategy.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
